Cytek Biosciences, Inc. revenue breakdown overview

Cytek Biosciences, Inc. revenue for the last year amounted to 200.45 M USD, the most of which — 153.26 M USD — came from its highest performing source at the moment, Full Spectrum Flow Cytometry Platform, the year earlier bringing 156.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cytek Biosciences, Inc. 92.61 M USD, and the year before that — 102.08 M USD.